1. 1) Antonella, F., Wayne, A.C., Aileen, M.B., Joan, C.M. (2011): New perspectives on osteogenesis imperfecta. Nature Reviews Endocrinology. 7: 540-557.
2. 2) Balena, R., Markatos, A., Seedor, J.G., Gentile, M., Stark, Christopher., Peter, C.P., Rodan, G.A. (1995): Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae. J. Pharm. Exper. Thera. 276: 277-283.
3. 3) Boskey, A.L., Wright, T.M., Blank, R.D. (1999): Collagen and bone strength. J. Bone Miner. Res. 14: 330-335.
4. 4) Burnei, G., Vlad, C., Georgescu, I., Gavriliu, T.S., Dan, D. (2008): Osteogenesis imperfecta: diagnosis and treatment. J. Am. Acad. Orthop. Surg. 16: 356-366.
5. 5) Burr, D.B., Allen, M.R. (2009): Mandubular necrosis in beagle dogs treated with bispthosphonates. Orthod. Craniofac. Res. 12(3): 221-228.